Akineton

Active Ingredient(s): Biperiden
FDA Approved: * September 8, 1959
Pharm Company: * ABBOTT
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Akineton Overview

Biperiden, sold under the brandname Akineton among others, is a medication used to treat Parkinson disease and certain drug-induced movement disorders.[1] It is not recommended for tardive dyskinesias.[2] It is taken by mouth, injection into a vein, or muscle.[1][2] Common side effects include blurred vision, dry mouth, sleepiness, constipation, and confusion.[1] It should not be used in people with a bowel obstru...

Read more Akineton Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Biperiden

Recent Akineton Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Biperiden
  • Injection: 5mg/ml
  • Tablet: 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Biperiden or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA